Related Experiment Video
Updated: Jan 23, 2026
Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation
Published on: July 15, 2015
Pharmacological Protection of Kidney Grafts from Cold Perfusion-Induced Injury
Anna Krzywonos-Zawadzka1, Aleksandra Franczak1, Michael A J Moser2,3
1Department of Medical Laboratory Diagnostics, Division of Clinical Chemistry, Wroclaw Medical University, Ul. Borowska 211A, 50-556 Wroclaw, Poland.
Abstract:
One of the greatest challenges facing the field of organ transplantation is the shortage of donor organs for transplantation. Renal transplantation increases quality of life and survival of patients suffering from end-stage renal disease. Although kidney transplantation has evolved greatly over the past few decades, a not insignificant amount of injury occurs to the kidney during recovery, preservation, and implantation and leads to the loss of function and loss of years of dialysis-free living for many patients. The use of kidneys from expanded criteria donors (ECD) and donation after circulatory determination of death (DCDD) has been adopted partly in response to the shortage of donor kidneys; however these kidneys are even more susceptible to ischemic injury. It has been shown that matrix metalloproteinases (MMPs) and reactive oxygen species (ROS) are involved in mechanisms of injury to the transplant kidney. There is also some evidence that inhibition of MMP activity and/or ROS production can protect the kidney from injury. We review possible pharmacological strategies for protection of kidney graft from injury during recovery, preservation, and implantation.
Insights
Donor kidney shortages impact transplantation. Protecting kidneys from injury during recovery, preservation, and implantation is crucial, especially for expanded criteria and DCDD donors, using strategies targeting matrix metalloproteinases and reactive oxygen species.
Area of Science:
- Transplantation immunology
- Nephrology
- Surgical innovation
Background:
- Organ transplantation faces a critical donor organ shortage, impacting end-stage renal disease patient outcomes.
- Kidney graft injury during recovery, preservation, and implantation reduces long-term function and patient survival.
- Expanded criteria donors (ECD) and donation after circulatory determination of death (DCDD) kidneys are more vulnerable to ischemic injury.
Purpose of the Study:
- To review pharmacological strategies for protecting kidney grafts from injury.
- To explore mechanisms of kidney transplant injury, including matrix metalloproteinases (MMPs) and reactive oxygen species (ROS).
- To identify potential therapeutic targets for mitigating ischemia-reperfusion injury in kidney transplantation.
Main Methods:
- Literature review of studies on kidney transplant injury mechanisms.
- Analysis of research on matrix metalloproteinases (MMPs) and reactive oxygen species (ROS) in graft damage.
- Evaluation of pharmacological interventions aimed at protecting kidney grafts.
Main Results:
- Matrix metalloproteinases (MMPs) and reactive oxygen species (ROS) are implicated in transplant kidney injury.
- Inhibition of MMP activity and/or ROS production shows potential in protecting kidney grafts.
- Pharmacological strategies may mitigate injury during critical peri-transplant periods.
Conclusions:
- Protecting kidney grafts from ischemic injury is vital for successful transplantation.
- Targeting MMPs and ROS represents a promising avenue for therapeutic intervention.
- Further research into pharmacological protection is warranted to improve outcomes for all kidney donors, including ECD and DCDD.
Related Concept Videos
01:22Acute Kidney Injury I: Introduction
01:29Acute Kidney Injury II: Pathophysiology
01:20Acute Kidney Injury V: Interprofessional Care
01:22Acute Kidney Injury VI: Nursing Management
01:29Acute Kidney Injury III: Clinical Manifestations
02:45Responses to Heat and Cold Stress